BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 22984603)

  • 21. Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model.
    Emmerson JT; Do Carmo S; Liu Y; Shalhoub A; Liu A; Bonomo Q; Malcolm JC; Breuillaud L; Cuello AC
    Neurobiol Dis; 2023 Aug; 184():106227. PubMed ID: 37454780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The difference in gliosis induced by β-amyloid and Tau treatments in astrocyte cultures derived from senescence accelerated and normal mouse strains.
    Lü L; Mak YT; Fang M; Yew DT
    Biogerontology; 2009 Dec; 10(6):695-710. PubMed ID: 19221889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
    Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D
    Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
    Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH
    Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.
    Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T
    Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline.
    Wang L; Liu M; Gao J; Smith AM; Fujioka H; Liang J; Perry G; Wang X
    J Alzheimers Dis; 2021; 84(3):1057-1069. PubMed ID: 34602490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model.
    Antón-Fernández A; Merchán-Rubira J; Avila J; Hernández F; DeFelipe J; Muñoz A
    J Alzheimers Dis; 2017; 60(2):651-661. PubMed ID: 28922155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.
    Javidnia M; Hebron ML; Xin Y; Kinney NG; Moussa CE
    J Alzheimers Dis; 2017; 60(2):461-481. PubMed ID: 28869476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
    Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
    Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.
    Stancu IC; Vasconcelos B; Ris L; Wang P; Villers A; Peeraer E; Buist A; Terwel D; Baatsen P; Oyelami T; Pierrot N; Casteels C; Bormans G; Kienlen-Campard P; Octave JN; Moechars D; Dewachter I
    Acta Neuropathol; 2015 Jun; 129(6):875-94. PubMed ID: 25862635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P2X
    Beltran-Lobo P; Hughes MM; Troakes C; Croft CL; Rupawala H; Jutzi D; Ruepp MD; Jimenez-Sanchez M; Perkinton MS; Kassiou M; Golde TE; Hanger DP; Verkhratsky A; Perez-Nievas BG; Noble W
    Brain Behav Immun; 2023 Nov; 114():414-429. PubMed ID: 37716378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy.
    Chen X; Firulyova M; Manis M; Herz J; Smirnov I; Aladyeva E; Wang C; Bao X; Finn MB; Hu H; Shchukina I; Kim MW; Yuede CM; Kipnis J; Artyomov MN; Ulrich JD; Holtzman DM
    Nature; 2023 Mar; 615(7953):668-677. PubMed ID: 36890231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration.
    Forman MS; Lal D; Zhang B; Dabir DV; Swanson E; Lee VM; Trojanowski JQ
    J Neurosci; 2005 Apr; 25(14):3539-50. PubMed ID: 15814784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease.
    Thangavel R; Stolmeier D; Yang X; Anantharam P; Zaheer A
    Neuropathol Appl Neurobiol; 2012 Oct; 38(6):572-81. PubMed ID: 22035352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
    Joly-Amado A; Hunter J; Quadri Z; Zamudio F; Rocha-Rangel PV; Chan D; Kesarwani A; Nash K; Lee DC; Morgan D; Gordon MN; Selenica MB
    Front Immunol; 2020; 11():997. PubMed ID: 32508844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
    Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
    Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.